Product Description
GS-441524 is a nucleoside analogue, which means it mimics a building block of RNA. When a virus infects a cell, it hijacks the cell's machinery to replicate itself. Nucleoside analogues like GS-441524 interfere with this process by being incorporated into the viral RNA during replication, which leads to errors in the viral genetic code and ultimately inhibits viral replication.
FIP is a particularly challenging disease to treat because it is caused by a type of coronavirus called feline coronavirus (FCoV). While most cats infected with FCoV experience mild or asymptomatic infections, a small percentage of cats develop FIP, which can be fatal. FIP occurs when the virus mutates within the cat's body, leading to an abnormal immune response and systemic inflammation.
GS-441524 has shown promise in treating FIP by inhibiting the replication of the mutated coronavirus responsible for the disease. Studies have demonstrated its ability to improve clinical signs, prolong survival, and even lead to complete remission in some cats with FIP. However, it's important to note that GS-441524 is not a cure for FIP, and outcomes can vary depending on factors such as the cat's age, overall health, and the stage of the disease at the time of treatment.
The powder formulation of GS-441524 allows for convenient storage and preparation of the medication for administration to cats. Veterinarians typically reconstitute the powder with a sterile diluent before administering it to the cat subcutaneously (under the skin). Treatment protocols may vary, but close monitoring by a veterinarian is essential to ensure proper dosing and to monitor for any potential side effects.
| Appearance | White powder |
| GS Standard | 99.5%min |
| CAS | 1191237-69-0 |
